fledged 发表于 2025-3-23 12:24:24

https://doi.org/10.1007/978-1-4842-4950-5sons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.

勾引 发表于 2025-3-23 16:21:52

Installing Third-Party Libraries,linical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.

Amylase 发表于 2025-3-23 19:48:03

Clinical guidelines — a help or a hindrance?cceed, now and again, in thwarting their deliberations and obscuring their aims. The issue of Guidelines for the Clinical Investigation of Drugs is a case in point. They are hailed by some and condemned by others and nine tenths of the problem is that the one party really has little idea what the other party is talking about.

Aspiration 发表于 2025-3-23 23:51:22

http://reply.papertrans.cn/29/2833/283216/283216_14.png

FLIP 发表于 2025-3-24 03:04:13

Alternatives to clinical trials in post-marketing research on drug effectslinical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.

MELON 发表于 2025-3-24 07:28:05

Managing Device Drivers and PC ResourcesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.

SLAY 发表于 2025-3-24 10:44:29

http://reply.papertrans.cn/29/2833/283216/283216_17.png

翅膀拍动 发表于 2025-3-24 14:49:36

The organisation of long-term intervention and prevention studiesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.

反对 发表于 2025-3-24 20:33:56

http://reply.papertrans.cn/29/2833/283216/283216_19.png

保留 发表于 2025-3-25 00:30:33

http://reply.papertrans.cn/29/2833/283216/283216_20.png
页: 1 [2] 3 4 5 6 7
查看完整版本: Titlebook: Drugs between Research and Regulations; Proceedings of the 5 C. Steichele (Medizinischer Direktor),U. Abshagen Conference proceedings 1985